{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T04:53:27Z","timestamp":1785041607047,"version":"3.55.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["JAHA"],"published-print":{"date-parts":[[2020,1,7]]},"abstract":"<jats:sec xml:lang=\"en\">\n            <jats:title>Background<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              The contemporary impact of glycemic control on patients with diabetes mellitus at high cardiovascular risk remains unclear. We evaluated the utility of hemoglobin A1c (HbA1c) as a marker of risk on the composite end point of cardiovascular death, nonfatal myocardial infarction, stroke, hospitalization for unstable angina, and coronary revascularization in an optimally treated population with diabetes mellitus and established coronary artery disease enrolled in the\n              <jats:styled-content style=\"fixed-case\">ACCELERATE<\/jats:styled-content>\n              (Assessment of Clinical Effects of Cholesteryl Ester Transfer Protein Inhibition With Evacetrapib in Patients at a High Risk for Vascular Outcomes) trial.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Methods and Results<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              We included all patients with established diabetes mellitus and measured HbA1c (N=8145) and estimated Kaplan\u2010Meier (KM) events rates, stratified by increasing baseline HbA1c levels censored at 30\u00a0months. We then performed a multivariable regression for the primary end point. Increasing baseline HbA1c was strongly associated with the occurrence of the primary end point (KM estimate, 12.6\u201318.2;\n              <jats:italic>P<\/jats:italic>\n              &lt;0.001). Increasing baseline HbA1c was also associated with the triple end point of death, nonfatal myocardial infarction, and stroke (KM estimate, 7.8\u201311.3;\n              <jats:italic>P<\/jats:italic>\n              =0.003) as well as the individual end points of nonfatal myocardial infarction (KM estimate, 3.1\u20137.0;\n              <jats:italic>P<\/jats:italic>\n              &lt;0.001), hospitalization for unstable angina (KM estimate, 1.8\u20135.0;\n              <jats:italic>P<\/jats:italic>\n              =0.003), and revascularization (KM estimate, 7.3\u201311.1;\n              <jats:italic>P<\/jats:italic>\n              =0.001), although not stroke (KM estimate, 1.4\u20132.4;\n              <jats:italic>P<\/jats:italic>\n              =0.45). The rates of cardiovascular mortality (KM estimate, 2.6\u20134.3;\n              <jats:italic>P<\/jats:italic>\n              =0.21) and all\u2010cause mortality (\n              <jats:styled-content style=\"fixed-case\">KM<\/jats:styled-content>\n              estimate, 4.8\u20135.9;\n              <jats:italic>P<\/jats:italic>\n              =0.21) were similar regardless of baseline HbA1c levels. When adjusting for relevant baseline characteristics, baseline HbA1c was an independent predictor for the primary end point (hazard ratio, 1.06; 95%\n              <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n              , 1.02\u20131.11;\n              <jats:italic>P<\/jats:italic>\n              =0.003).\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p xml:lang=\"en\">Glycemic control, as measured by HbA1c, remains strongly and independently associated with cardiovascular outcomes in high\u2010risk patients with diabetes mellitus on statin therapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Clinical Trial Registration<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              <jats:styled-content style=\"fixed-case\">URL<\/jats:styled-content>\n              :\n              <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.clinicaltrials.gov\">https:\/\/www.clinicaltrials.gov<\/jats:ext-link>\n              . Unique identifier:\n              <jats:styled-content style=\"fixed-case\">NCT<\/jats:styled-content>\n              01687998.\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/jaha.119.014328","type":"journal-article","created":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T10:00:29Z","timestamp":1576749629000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":16,"title":["Impact of Baseline Glycemic Control on Residual Cardiovascular Risk\u00a0in Patients With Diabetes Mellitus and High\u2010Risk Vascular Disease Treated With Statin Therapy"],"prefix":"10.1161","volume":"9","author":[{"given":"Venu","family":"Menon","sequence":"first","affiliation":[{"name":"Heart and Vascular Institute Cleveland Clinic Foundation Cleveland OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anirudh","family":"Kumar","sequence":"additional","affiliation":[{"name":"Heart and Vascular Institute Cleveland Clinic Foundation Cleveland OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divyang R.","family":"Patel","sequence":"additional","affiliation":[{"name":"Heart and Vascular Institute Cleveland Clinic Foundation Cleveland OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"St. John","sequence":"additional","affiliation":[{"name":"Heart and Vascular Institute Cleveland Clinic Foundation Cleveland OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy E.","family":"Wolski","sequence":"additional","affiliation":[{"name":"Heart and Vascular Institute Cleveland Clinic Foundation Cleveland OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"McErlean","sequence":"additional","affiliation":[{"name":"Heart and Vascular Institute Cleveland Clinic Foundation Cleveland OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Riesmeyer","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company Indianapolis IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Govinda","family":"Weerakkody","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company Indianapolis IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Ruotolo","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company Indianapolis IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul C.","family":"Cremer","sequence":"additional","affiliation":[{"name":"Heart and Vascular Institute Cleveland Clinic Foundation Cleveland OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Nicholls","sequence":"additional","affiliation":[{"name":"Monash Cardiovascular Research Centre Monash University Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Michael","family":"Lincoff","sequence":"additional","affiliation":[{"name":"Heart and Vascular Institute Cleveland Clinic Foundation Cleveland OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven E.","family":"Nissen","sequence":"additional","affiliation":[{"name":"Heart and Vascular Institute Cleveland Clinic Foundation Cleveland OH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1008862"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60484-9"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-9033"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-0545"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-S062"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht108"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.08.070"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx668"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1609581"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2015.09.007"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc05-1973"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61969-3"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802987"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808431"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802743"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1900\/RDS.2014.11.138"}],"container-title":["Journal of the American Heart Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/JAHA.119.014328","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:55:43Z","timestamp":1715597743000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/JAHA.119.014328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,7]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1,7]]}},"alternative-id":["10.1161\/JAHA.119.014328"],"URL":"https:\/\/doi.org\/10.1161\/jaha.119.014328","relation":{},"ISSN":["2047-9980"],"issn-type":[{"value":"2047-9980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,7]]},"assertion":[{"value":"2019-08-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-25","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e014328"}}